These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8865703)

  • 41. Ketorolac is not nephrotoxic in connection with sevoflurane anesthesia in patients undergoing breast surgery.
    Laisalmi M; Eriksson H; Koivusalo AM; Pere P; Rosenberg P; Lindgren L
    Anesth Analg; 2001 Apr; 92(4):1058-63. PubMed ID: 11273951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal function after sevoflurane or enflurane anesthesia in the Fischer 344 rat.
    Malan TP; Kadota Y; Mata H; Frink EJ; Brown BR
    Anesth Analg; 1993 Oct; 77(4):817-21. PubMed ID: 8214671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship of inspired anesthetic concentration to plasma concentration and urinary excretion of sevoflurane metabolites in rats.
    Malan TP; Sameshima T; Mata H; Frink EJ
    Anesth Analg; 1995 Sep; 81(3):576-80. PubMed ID: 7653826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal and hepatic integrity in long-term sevoflurane sedation using the anesthetic conserving device: a comparison with intravenous propofol sedation in an animal model.
    Gallego L; Soro M; Alvariño A; Noguera I; Belda FJ
    Rev Esp Anestesiol Reanim; 2015 Apr; 62(4):191-203. PubMed ID: 25146774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary excretion of inorganic and organic fluoride after inhalation of sevoflurane.
    Davidkova TI; Fujii K; Kikuchi H; Horibe M; Mukaida K; Sato N; Morio M
    Hiroshima J Med Sci; 1987 Mar; 36(1):99-104. PubMed ID: 3583810
    [No Abstract]   [Full Text] [Related]  

  • 46. Renal integrity in sevoflurane sedation in the intensive care unit with the anesthetic-conserving device: a comparison with intravenous propofol sedation.
    Röhm KD; Mengistu A; Boldt J; Mayer J; Beck G; Piper SN
    Anesth Analg; 2009 Jun; 108(6):1848-54. PubMed ID: 19448211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effects of inorganic fluoride, inhalation time and dosage of sevoflurane on renal function during sevoflurane anesthesia of long duration].
    Nishiyama T; Nagase M; Tamai H; Watanabe S; Hirasaki A
    Masui; 1994 Dec; 43(12):1846-50. PubMed ID: 7837402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating fluoride changes and hepatorenal function following sevoflurane anaesthesia.
    Newman PJ; Quinn AC; Hall GM; Grounds RM
    Anaesthesia; 1994 Nov; 49(11):936-9. PubMed ID: 7802235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical characteristics and biotransformation of sevoflurane in paediatric patients during antiepileptic drug therapy.
    Komatsu H; Ueki M; Morita J; Chujo K; Ogli K
    Paediatr Anaesth; 1996; 6(5):379-82. PubMed ID: 8880818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A successful cadaveric renal-transplantation in a patient whose serum inorganic fluoride concentrations were extremely elevated during sevoflurane anesthesia].
    Okutani R; Uemura Y; Tanimoto M; Kurehara H; Fukushima A
    Masui; 1999 Jul; 48(7):778-81. PubMed ID: 10434521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers.
    Goldberg ME; Cantillo J; Gratz I; Deal E; Vekeman D; McDougall R; Afshar M; Zafeiridis A; Larijani G
    Anesth Analg; 1999 Feb; 88(2):437-45. PubMed ID: 9972771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Uptaken distribution and metabolism of sevoflurane].
    Dudziak R; Vettermann J
    Anaesthesist; 1996 Feb; 45 Suppl 1():S1-9. PubMed ID: 8775096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inorganic fluoride kinetics and renal and hepatic function after repeated sevoflurane anesthesia.
    Nishiyama T; Hanaoka K
    Anesth Analg; 1998 Aug; 87(2):468-73. PubMed ID: 9706952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Sevoflurane in pediatric anesthesia].
    Hobbhahn J; Funk W
    Anaesthesist; 1996 Feb; 45 Suppl 1():S22-7. PubMed ID: 8775099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pharmacokinetic study of 48-hour sevoflurane inhalation using a disposable delivery system (AnaConDa®) in ICU patients.
    Perbet S; Bourdeaux D; Sautou V; Pereira B; Chabanne R; Constantin JM; Chopineau J; Bazin JE
    Minerva Anestesiol; 2014 Jun; 80(6):655-65. PubMed ID: 24226486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluoride excretion in children after sevoflurane anaesthesia.
    Lejus C; Le Roux C; Legendre E; Renaudin M; Boiteau HL; Pinaud M
    Br J Anaesth; 2002 Nov; 89(5):693-6. PubMed ID: 12393764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Serum and urinary inorganic fluoride concentrations with renal and hepatic functions after repeated sevoflurane anesthesia].
    Takenami T; Arai M; Matsuzaki S; Anzai K; Ueno T; Hoka S
    Masui; 2002 Oct; 51(10):1086-93. PubMed ID: 12428311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Open-label Comparison of a New Generic Sevoflurane Formulation With Original Sevoflurane in Patients Scheduled for Elective Surgery Under General Anesthesia.
    Byon HJ; Choi BM; Bang JY; Lee EK; Lee SS; Noh GJ
    Clin Ther; 2015 Apr; 37(4):887-901. PubMed ID: 25697421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The use of lithium hydroxide for carbon dioxide absorption prevents formation of compound A during sevoflurane anesthesia].
    Förster H; Behne M; Warnken UH; Asskali F; Dudziak R
    Anaesthesist; 2000 Feb; 49(2):106-12. PubMed ID: 10756964
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inorganic fluoride kinetics and renal tubular function after sevoflurane anesthesia in chronic renal failure patients receiving hemodialysis.
    Nishiyama T; Aibiki M; Hanaoka K
    Anesth Analg; 1996 Sep; 83(3):574-7. PubMed ID: 8780284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.